[{"address1": "444 West Lake Street", "address2": "Suite 1700", "city": "Chicago", "state": "IL", "zip": "60606", "country": "United States", "phone": "312 416 8592", "website": "https://maiabiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vlad  Vitoc M.B.A., M.D.", "age": 54, "title": "Co-Founder, President, CEO & Chairman of the Board of Directors", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 529823, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey C. Himmelreich", "age": 49, "title": "Head of Finance", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 213173, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sergei M. Gryaznov Ph.D.", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 417334, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Linda  Moreira", "title": "Company Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.87, "open": 1.87, "dayLow": 1.83, "dayHigh": 1.9096, "regularMarketPreviousClose": 1.87, "regularMarketOpen": 1.87, "regularMarketDayLow": 1.83, "regularMarketDayHigh": 1.9096, "beta": 0.217, "forwardPE": -1.3851851, "volume": 67386, "regularMarketVolume": 67386, "averageVolume": 314981, "averageVolume10days": 624320, "averageDailyVolume10Day": 624320, "bid": 1.85, "ask": 1.9, "bidSize": 1000, "askSize": 3100, "marketCap": 48915088, "fiftyTwoWeekLow": 1.24, "fiftyTwoWeekHigh": 5.99, "fiftyDayAverage": 2.0244, "twoHundredDayAverage": 2.81192, "currency": "USD", "enterpriseValue": 38680184, "floatShares": 20961780, "sharesOutstanding": 26157800, "sharesShort": 674279, "sharesShortPriorMonth": 682377, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.025799999, "heldPercentInsiders": 0.16188, "heldPercentInstitutions": 0.05287, "shortRatio": 2.21, "shortPercentOfFloat": 0.030299999, "impliedSharesOutstanding": 26157800, "bookValue": 0.068, "priceToBook": 27.499998, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -25939380, "trailingEps": -1.34, "forwardEps": -1.58, "52WeekChange": 0.31690145, "SandP52WeekChange": 0.22903383, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "MAIA", "underlyingSymbol": "MAIA", "shortName": "MAIA Biotechnology, Inc.", "longName": "MAIA Biotechnology, Inc.", "firstTradeDateEpochUtc": 1659015000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "0f42043f-a188-3808-9a57-e38f76c4260b", "messageBoardId": "finmb_631239285", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.87, "targetHighPrice": 14.0, "targetLowPrice": 11.25, "targetMeanPrice": 12.625, "targetMedianPrice": 12.625, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 8690784, "totalCashPerShare": 0.343, "quickRatio": 2.423, "currentRatio": 2.56, "returnOnAssets": -1.41056, "returnOnEquity": -11.881619, "freeCashflow": -9437114, "operatingCashflow": -15788732, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]